Literature DB >> 31602391

Risk Assessment for Tobacco Regulation.

Micah L Berman1, Taleed El-Sabawi2, Peter G Shields3.   

Abstract

Risk assessment is a process that uses a transparent, reproducible and pre-established methodology to evaluate alternatives for managing health-related risks. Although an array of federal agencies regularly use risk assessment to inform regulatory decisions, its application to tobacco regulation is new. By comparing examples of FDA risk assessments for food and tobacco, this paper highlights some of the challenges inherent in applying risk assessment methodologies to tobacco regulation. In doing so, it calls upon researchers to work with the FDA to develop a tobacco-specific approach to risk assessment that reflects the Tobacco Control Act's regulatory framework and the distinctive features of tobacco products and tobacco use.

Entities:  

Keywords:  modeling; population health; product standard; risk assessment; tobacco regulation

Year:  2019        PMID: 31602391      PMCID: PMC6786779          DOI: 10.18001/TRS.5.1.4

Source DB:  PubMed          Journal:  Tob Regul Sci        ISSN: 2333-9748


  14 in total

1.  Reducing tobacco-related harm: FDA's proposed product standard for smokeless tobacco.

Authors:  Micah L Berman; Dorothy K Hatsukami
Journal:  Tob Control       Date:  2017-06-20       Impact factor: 7.552

Review 2.  A survey of frameworks for best practices in weight-of-evidence analyses.

Authors:  Lorenz R Rhomberg; Julie E Goodman; Lisa A Bailey; Robyn L Prueitt; Nancy B Beck; Christopher Bevan; Michael Honeycutt; Norbert E Kaminski; Greg Paoli; Lynn H Pottenger; Roberta W Scherer; Kimberly C Wise; Richard A Becker
Journal:  Crit Rev Toxicol       Date:  2013-10       Impact factor: 5.635

Review 3.  A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products.

Authors:  David T Levy; K Michael Cummings; Andrea C Villanti; Ray Niaura; David B Abrams; Geoffrey T Fong; Ron Borland
Journal:  Addiction       Date:  2016-04-25       Impact factor: 6.526

4.  A novel approach to assess the population health impact of introducing a Modified Risk Tobacco Product.

Authors:  Rolf Weitkunat; Peter N Lee; Gizelle Baker; Zheng Sponsiello-Wang; Angela M González-Zuloeta Ladd; Frank Lüdicke
Journal:  Regul Toxicol Pharmacol       Date:  2015-03-27       Impact factor: 3.271

5.  CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study.

Authors:  Jian-Min Yuan; Heather H Nelson; Steven G Carmella; Renwei Wang; Jacquelyn Kuriger-Laber; Aizhen Jin; Jennifer Adams-Haduch; Stephen S Hecht; Woon-Puay Koh; Sharon E Murphy
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

6.  Estimating the effect of differing assumptions on the population health impact of introducing a Reduced Risk Tobacco Product in the USA.

Authors:  Peter N Lee; John S Fry; John F Hamling; Zheng Sponsiello-Wang; Gizelle Baker; Rolf Weitkunat
Journal:  Regul Toxicol Pharmacol       Date:  2017-06-24       Impact factor: 3.271

7.  Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users.

Authors:  Stephen S Hecht; Steven G Carmella; Irina Stepanov; Joni Jensen; Amanda Anderson; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

8.  Defining Tobacco Regulatory Science Competencies.

Authors:  Heather L Wipfli; Micah Berman; Kacey Hanson; Steven Kelder; Amy Solis; Andrea C Villanti; Carla M P Ribeiro; Helen I Meissner; Roger Anderson
Journal:  Nicotine Tob Res       Date:  2016-07-14       Impact factor: 4.244

Review 9.  Smokeless tobacco and cancer.

Authors:  Paolo Boffetta; Stephen Hecht; Nigel Gray; Prakash Gupta; Kurt Straif
Journal:  Lancet Oncol       Date:  2008-07       Impact factor: 41.316

10.  Population Modeling of Modified Risk Tobacco Products Accounting for Smoking Reduction and Gradual Transitions of Relative Risk.

Authors:  Bill Poland; Florian Teischinger
Journal:  Nicotine Tob Res       Date:  2017-11-01       Impact factor: 4.244

View more
  2 in total

1.  Methodological Approaches for Risk Assessment of Tobacco and Related Products.

Authors:  Yvonne C M Staal; Peter M J Bos; Reinskje Talhout
Journal:  Toxics       Date:  2022-08-24

2.  Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis.

Authors:  Micah L Berman; Allison M Glasser
Journal:  Nicotine Tob Res       Date:  2019-12-23       Impact factor: 4.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.